Cargando…
Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
BACKGROUND: Oral and intravenous formulations of ciprofloxacin have established efficacy and safety profiles in respiratory infections. A dry powder for inhalation (DPI) that uses Novartis’ PulmoSphere™ technology has been developed to deliver high concentrations of ciprofloxacin to the lung with lo...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing AG
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664741/ https://www.ncbi.nlm.nih.gov/pubmed/23605507 http://dx.doi.org/10.1007/s40261-013-0082-0 |